The Effect of Methylene Blue Infiltrating Injection on Anal Pain After Milligan-Morgan Surgery: a Randomized Controlled Clinical Study
NCT ID: NCT06660680
Last Updated: 2024-10-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
PHASE3
60 participants
INTERVENTIONAL
2024-10-25
2025-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methylene blue (MB), a cationic thiazine dye extensively utilized as a biological stain and chemical indicator, has been increasingly recognized for its potential analgesic properties (9). In the present study, methylene blue infiltrating injection (MBI) was administered to treat anal pain resulting from Milligan-Morgan surgery, with the aim of assessing its analgesic efficacy and safety profile.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Impact of Methylene Blue on the Quality of Recovery in Patients Undergoing Hemorrhoidectomy
NCT06747195
A Multi Center Clinical Trial of Rph With the Simplified Milligan-Morgan Surgery on Treatment of Mixed Hemorrhoids
NCT02306421
Reduction of Postoperative Pain After Milligan-Morgan Haemorrhoidectomy With Application of Vitamin E Ointment
NCT02554123
Topical vs Oral Metronidazole After Benign Anorectal Surgery
NCT05038605
Preoperative Micronized Flavonoid Fraction (MFF) Use in Multimodal Anesthesia in Anorectal Surgery
NCT05772351
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Group
received MBI treatment to their surgical incisions upon completion of surgery
Methylene Blue
Received MBI treatment to their surgical incisions upon completion of surgery
Control group
administered lornoxicam on an as-needed basis for analgesia.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Methylene Blue
Received MBI treatment to their surgical incisions upon completion of surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Heng Deng
the second Hospital of Chinese Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Second hospital affiliated Anhui University of Chinese Medicine
Hefei, Anhui, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Anorectal Branch of Chinese Medical Doctor A, Colorectal Surgery Group SSoCMA.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
(No. 2023AH050848)
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
HFBH2021011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.